Evidence map›Paper›PMID 42741219›Full record

ArticleFrontiers in immunology2026

Glymphatic surrogate, choroid plexus remodeling, and exploratory brain network analysis in the post-acute phase of anti-NMDAR encephalitis: multimodal MRI evidence for cognitive associations and differential white matter mediation.

Run Du, Jinyu Tao, Junwei Xiong, Yayun Xiang, Qiyuan Zhu, Zhuowei Shi, Wenwen Wang, Yongmei Li, Chun Zeng

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Run DuDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jinyu TaoDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Junwei XiongDepartment of Otorhinolaryngology, Banan Hospital of Chongqing Medical University, Chongqing, China.
Yayun XiangDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qiyuan ZhuDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhuowei ShiDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wenwen WangDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yongmei LiDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chun ZengDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis typically presents with acute neuroinflammation, and many patients often experience persistent cognitive impairment during the post-acute/recovery phase. While impaired cerebrospinal fluid (CSF)-related markers-including glymphatic function and choroid plexus (CP) structural remodeling-are well documented in neurodegenerative diseases, their role in acute autoimmune brain injury remains unclear. Objective: To evaluate a glymphatic surrogate (diffusion tensor image analysis along the perivascular space (DTI-ALPS) index), choroid plexus structural remodeling (CP/intracranial volume (ICV) ratio), white matter microstructural integrity (global fractional anisotropy (FA) using tract-based spatial statistics (TBSS)), and structural covariance network (SCN) topology in anti-NMDAR encephalitis using multimodal MRI, and to investigate their associations with cognition, with an exploratory mediation analysis examining whether white matter microstructure mediates these associations. Methods: A total of 103 anti-NMDAR encephalitis patients and 97 healthy controls (HCs) with comparable sex distribution were enrolled. The glymphatic surrogate was evaluated by DTI-ALPS and CP structural remodeling was quantified by CP. White matter microstructural differences were analyzed using TBSS; mean FA values were extracted from all statistically significant clusters within the white matter skeleton (FA threshold = 0.2) after TFCE correction ( Results: Compared to HCs, patients with anti-NMDAR encephalitis showed significantly decreased bilateral DTI-ALPS indices (left: 1.361 ± 0.196 vs. 1.489 ± 0.178; right: 1.335 ± 0.183 vs. 1.483 ± 0.174; Conclusions: Patients with anti-NMDAR encephalitis exhibit concurrent glymphatic function, CP structural remodeling, widespread white matter microstructural damage, and topological reorganization. The CP/ICV ratio emerged as the primary imaging correlate of cognitive dysfunction. Although exploratory mediation suggested that FA partially accounted for the ALPS-cognition association, this likely reflects shared methodological collinearity rather than a distinct biological pathway, reinforcing CP/ICV as the more robust clinically relevant marker.These findings extend the concept of glymphatic-choroid plexus pathology from neurodegenerative diseases to post-acute autoimmune brain injury, providing a framework for non-invasive biomarkers in anti-NMDAR encephalitis.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisChoroid PlexusCognitionGlymphatic SystemWhite MatterAdultBiomarkersDiffusion Tensor ImagingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingYoung AdultBiomarkersALPS indexanti-N-methyl-D-aspartate receptor encephalitisbrain networkchoroid plexuscognitive functionglymphatic systemmultimodal MRItract-based spatial statistics

Identifiers

PMID42741219
PMCPMC13572916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.